Septerna, Inc. insider trading
Every open-market purchase and sale by Septerna, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Septerna, Inc.’s insiders pay?
From February 21, 2025 to August 14, 2026, 6 insiders reported 7 open-market purchases and 2 sales not made under a pre-set plan in Septerna, Inc. Twelve months after each purchase was reported, the shares were +348.8% against the S&P 500 on average (median +318.9%), over 7 purchases with a full year of prices; 100% beat the index. That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on February 24, 2025 into $47,084 by November 2, 2026, +150.6% a year. It held shares 62% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $11,749 (+10.0% a year), and held throughout $12,916 (+16.4%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Ezekowitz Alan | Director | 2 | +295.7% (2) | 100% | 0 | — | March 10, 2025 |
| Labrucherie Gil M | Chief Financial Officer | 2 | +362.4% (2) | 100% | 0 | — | February 27, 2025 |
| Third Rock Ventures Gp V, LP | 10% owner | 2 | +403.1% (2) | 100% | 0 | — | February 26, 2025 |
| Finer Jeffrey | CEO and President | 1 | +318.9% (1) | 100% | 0 | — | February 27, 2025 |
| Long Daniel D. | SVP, Drug Discovery | 0 | — | — | 1 | — | November 13, 2025 |
| Shah Rajeev M. | Director | 0 | — | — | 1 | — | August 14, 2026 |
When several insiders traded Septerna, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Septerna, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 1 buying crowd with six months of prices, it averaged +77.8% against the index. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| February 28, 2025 | 3 buying | +43.5% | +77.8% | +318.9% |